ANNEXSupplementary provisions
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) Row 220 on the active substance aluminium silicate is replaced by the following: Number Common Name, Identification Numbers IUPAC Name Purity ( *1 ) Date of approval Expiration of approval Specific provisions ‧220 Aluminium silicate CAS No 1332-58-7 CIPAC No 841 Not available Chemical name: Aluminium silicate ≥ 999,8 g/kg 1 September 2009 31 August 2019 PART A Only uses as repellent may be authorised. PART B For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on aluminium silicate (SANCO/2603/08) and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 1 June 2012 shall be taken into account. In this overall assessment Member States shall pay particular attention to the operator safety; conditions of use shall include the application of adequate personal and respiratory protective equipment, where appropriate. Conditions of use shall include, where appropriate, risk mitigation measures. The Member States concerned shall ensure that the applicant submits to the Commission confirmatory information as regards: (a) the specification of the technical material, as commercially manufactured, supported by appropriate analytical data; (b) the relevance of the test material used in the toxicity dossier in view of the specification of the technical material. The Member States concerned shall ensure that the applicant submits such information to the Commission by 1 May 2013.‧ (2) Row 234 on the active substance hydrolysed proteins is replaced by the following: ‧Number Common Name, Identification Numbers IUPAC Name Purity ( *2 ) Date of approval Expiration of approval Specific provisions 234 Hydrolysed proteins CAS No not allocated CIPAC No 901 Not available Review report (SANCO/2615/2008) 1 September 2009 31 August 2019 PART A Only uses as attractant may be authorised. Hydrolysed proteins of animal origin must be in compliance with Regulation (EC) No 1069/2009 ( *3 ) and Commission Regulation (EU) No 142/2011 ( *4 ) . PART B For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on hydrolysed proteins (SANCO/2615/08) and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 1 June 2012 shall be taken into account. In this overall assessment Member States shall pay particular attention to the operator and worker safety; conditions of use shall include the application of adequate personal protective equipment, where appropriate. Conditions of use shall include, where appropriate, risk mitigation measures. The Member States concerned shall ensure that the applicant submits to the Commission confirmatory information as regards: (a) the specifications of the technical material, as commercially manufactured, supported by appropriate analytical data; (b) the risk to aquatic organisms. The Member States concerned shall ensure that the applicant submits to the Commission the information set out in point (a) by 1 May 2013, the information set out in point (b) by 1 November 2013. (3) Row 245 on the active substance 1,4-diaminobutane (putrescine) is replaced by the following: Number Common Name, Identification Numbers IUPAC Name Purity ( *5 ) Date of approval Expiration of approval Specific provisions ‧245 1,4-diaminobutane (putrescine) CAS No 110-60-1 CIPAC No 854 Butane-1,4-diamine ≥ 990 g/kg 1 September 2009 31 August 2019 PART A Only uses as attractant may be authorised. PART B For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on 1,4-diaminobutane (putrescine) (SANCO/2626/08) and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 1 June 2012 shall be taken into account. Conditions of use shall include, where appropriate, risk mitigation measures.‧ ( *1 ) Further details on identity and specification of active substances are provided in their review report. ( *2 ) Further details on identity and specification of active substances are provided in their review report. ( *3 ) OJ L 300, 14.11.2009, p. 1 . ( *4 ) OJ L 54, 26.2.2011, p. 1 .‧ ( *5 ) Further details on identity and specification of active substances are provided in their review report.